Editas Medicine, Inc. (EDIT) Total liabilities 2016–2025
Editas Medicine, Inc. (EDIT) total liabilities at each fiscal year-end, per SEC filings.
$159.2MFY2025 · since FY2016: $94.6M → $159.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $159.2M | -23.2% |
| FY2024 | $207.3M | +38.2% |
| FY2023 | $150.1M | -2.3% |
| FY2022 | $153.6M | +24.1% |
| FY2021 | $123.8M | -30.8% |
| FY2020 | $179.0M | -27.4% |
| FY2019 | $246.4M | +33.8% |
| FY2018 | $184.2M | +11.5% |
| FY2017 | $165.2M | +74.7% |
| FY2016 | $94.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice